<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01897259</url>
  </required_header>
  <id_info>
    <org_study_id>11.0566</org_study_id>
    <nct_id>NCT01897259</nct_id>
  </id_info>
  <brief_title>Comparison of Conservative Methods for the Treatment of Lateral Epicondylitis: A Randomized, Prospective Study</brief_title>
  <official_title>Comparison of Conservative Methods for the Treatment of Lateral Epicondylitis: A Randomized, Prospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Christine M. Kleinert Institute for Hand and Microsurgery</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Christine M. Kleinert Institute for Hand and Microsurgery</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective study where patients with lateral epicondylitis (tennis elbow) will be
      randomized into one of 4 possible treatments. The purpose is to individually examine the
      efficacy of each treatment, and determine if one treatment method is more effective than
      another. The four treatments are: corticosteriod injections, prolotherapy, NSAIDs
      (non-steroidal anti-inflammatory drugs) combined with physical therapy, and a placebo.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">June 2019</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Symptom Severity in pre intervention assessments</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Symptom severity in post-intervention assessments</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Functional status score pre-intervention</measure>
    <time_frame>12 months</time_frame>
    <description>The secondary outcome will be by means of functional status score by means of QuickDASH (Disabilities of Arm, Shoulder, and Hand) prior to intervention.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional status score severity- post intervention</measure>
    <time_frame>12 months</time_frame>
    <description>The secondary outcome will be the functional status score by means of the QuickDash (Disabilities of Arm, Shoulder and Hand) for post intervention</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Tennis Elbow</condition>
  <condition>Lateral Epicondylitis</condition>
  <arm_group>
    <arm_group_label>Corticosteroid Injections</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive 1 cc Kenalong 10 mg injection to the site every 6 weeks until clinical symptoms have resolved. They will also receive an anesthetic of 1cc 1% lidocaine in conjunction with the corticosteroid injection.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Prolotherapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants receive 1cc 50% Dextrose and 1 cc Sodium Morrhuate to the site every 6 weeks until symptoms resolve. These participants will also receive an anesthetic of 1cc 1% lidocaine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants will recieve placebo injections (1cc 1% lidocaine and 1cc normal saline).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Physical Therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will be prescribed NSAIDS (Diclofenac 75 mg BID) for 2 weeks. Participants will attend therapy for muscle stretches, soft tissue mobilization, and gradual strengthening.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo Injection</intervention_name>
    <description>Participants in the placebo group will recieve placebo injections (1cc 1% lidocaine and 1cc normal saline).</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Physical Therapy</intervention_name>
    <description>Subjects participating in the physical therapy group will attend physical therapy and be prescribed to NSAIDS. No prolotherapy or corticosteroid injections.</description>
    <arm_group_label>Physical Therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Corticosteroid Injections</intervention_name>
    <description>Participants in the corticosteroid group will recieve corticosteroid injections (1 cc Kenalog 10 mg). They will also recieve anesthetic of 1 ml 1% lidocaine.</description>
    <arm_group_label>Corticosteroid Injections</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Prolotherapy</intervention_name>
    <description>Subjects participating in the prolotherapy group will recieve 1 cc 50% Dextrose and Sodium Morrhuate 1 cc injections.</description>
    <arm_group_label>Prolotherapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  pain over the lateral epicondyle (via palpation over the lateral epicondyle, resisted
             wrist extension, resisted finger extension of the middle finger) for less than
             six-months duration prior to enrollment

          -  conservative treatment of tennis elbow is recommended as standard of care treatment

          -  over the age of 18 and under the age of 65

          -  ability to give informed consent

        Exclusion Criteria:

          -  treatment by a health care profession (MD, physicians assistnat, therapist, or nurse
             practitioner) within the previous 6 months for tennis elbow

          -  congenital deformities, tendon ruptures, or fractures of the elbow within the previous
             12 months

          -  immobility casts or splints within the last 6 months for tennis elbow

          -  co-existing elbow diagnosis (i.e. osteoarthritis or instability)

          -  pregnant women, women trying to get pregnant, or breastfeeding women

          -  under the age of 18 or over the age of 65
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tuna Ozyurekoglu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Christine M. Kleinert Institute for Hand and Microsurgery</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tuna Ozyurekoglu, MD</last_name>
    <phone>502-561-4286</phone>
    <email>tozyurekoglu@kleinertkutz.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Millicent L Horn, BS</last_name>
    <phone>502-562-0307</phone>
    <email>mhorn@cmki.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Christine M. Kleinert Institute of Hand and Microsurgery</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christina L Kaufman, PhD</last_name>
      <phone>502-562-0390</phone>
      <email>ckaufman@cmki.org</email>
    </contact>
    <contact_backup>
      <last_name>Millicent L Horn, BS</last_name>
      <phone>502-562-0307</phone>
      <email>mhorn@cmki.org</email>
    </contact_backup>
    <investigator>
      <last_name>Tuna Ozyurekoglu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 11, 2012</study_first_submitted>
  <study_first_submitted_qc>July 9, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 11, 2013</study_first_posted>
  <last_update_submitted>January 23, 2018</last_update_submitted>
  <last_update_submitted_qc>January 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>tennis elbow</keyword>
  <keyword>lateral epicondylitis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tennis Elbow</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Sodium Morrhuate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

